artemether Injection 80 mg
Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19464
This company is a leading generic pharmaceutical manufacturer with over six decades of experience. They produce a wide range of products, including prescription medications, over-the-counter drugs, injectables, liquids, and external preparations. Their therapeutic areas include antibiotics, anti-diabetics, anti-malarials, NSAIDs, cardiology medications, central nervous system drugs, gastrointestinal agents, hormones, respiratory/anti-allergic medications, urology/infertility treatments, and health supplements. The company holds various certifications including ISO 9001, ISO 15378, GMP, WHO-GMP, and FSSAI. They export their products to over 30 countries across the globe, with a significant portion of their turnover coming from international operations. They emphasize quality assurance through rigorous testing and analysis at various stages of product development and manufacturing.
Manufacturer usually replies in 11 days
Artemether is a medication used to treat malaria. Although manufacturers of artemether produce drugs with it as the standalone ingredient, it is almost always marketed in combination with lumefantrine. Artemether suppliers market it in the form of oral tablets as well as injectable solutions.
The developer and earliest manufacturer of artemether/lumefantrine medications is Novartis, who markets it under the trade name Coartem. The standalone formulation was first introduced into medical use in 1987, whereas the artemether/lumefantrine combination formulation was first approved in 1992. Both drugs have since gained approvals in over 80 countries worldwide, including the U.S., China, numerous African countries and across Europe. What is more, the drug has become included in the World Health Organization’s list of Essential Medicines that contains the most important medications recommended for a basic health system.
Alternatives to artemether are other artemisinin class malaria drugs such as dihydroartemisinin and artesunate.
The prices of artemether medications are not particularly high. Its wholesale cost in the developing world typically falls into a range of 0,10 EUR to 1,00 EUR per daily treatment dose.